Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer
Roberta Roncarati(Institute of Genetic and Biomedical Research), Massimo Negrini(University of Ferrara), Elisa Callegari(University of Ferrara), Elena Saccenti(University of Ferrara), Valentina Conti(University of the Republic of San Marino), Alberto Papi(University of Ferrara), Laura Lupini(University of Ferrara), Giovanni Lanza(University of Ferrara), Roberta Gafà(University of Ferrara), Susanna Mascetti(Arcispedale Sant'Anna), Luca Morandi(Arcispedale Sant'Anna), Antonio Frassoldati(University of Ferrara), Gian Luca Casoni(Arcispedale Sant'Anna), Rosa Rinaldi(Azienda Ospedaliera Carlo Poma), Silvia Sabbioni(University of Ferrara), Elena Miotto(University of Ferrara), Cristian Bassi(University of Ferrara), Debora Rasio(Azienda Ospedaliera Sant'Andrea), F Ravenna(Azienda Ospedaliera Carlo Poma)
Cited by 30
Related Papers
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|337
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254